Table 2.
Key clinical and health parameters
PFS (credible intervals) | OS (credible intervals) | |
Weibull scale for F&A | 0.0758 (0.0739–0.0777) | 0.0009 (0.0006–0.0012) |
Weibull shape for F&A | 0.7776 (0.7703–0.7894) | 1.1094 (1.0936–1.1252) |
R2 for F&A | 0.9959 | 0.9922 |
Weibull scale for FUL | 0.0272 (0.0265–0.0279) | 0.0045 (0.0043–0.0046) |
Weibull shape for FUL | 1.1029 (1.0950–1.1107) | 1.3391 (1.3292–1.3491) |
R2 for FUL | 0.9946 | 0.9901 |
Weibull scale for ANA | 0.0598 (0.0582–0.0615) | 0.0073 (0.0072–0.0075) |
Weibull shape for ANA | 0.9581 (0.9485–0.9677) | 1.2327 (1.2267–1.2387) |
R2 for ANA | 0.9922 | 0.9972 |
ANA, anastrozole; F&A, half-dose fulvestrant plus anastrozole treatment group; FUL, fulvestrant; OS, overall survival; PFS, progression-free survival.